Polycythemia overview: Difference between revisions

Jump to navigation Jump to search
Line 9: Line 9:


==Historical Perspective==
==Historical Perspective==
In 2005, a mutation in the ''[[JAK2]]'' kinase (V617F) was found in multiple patients with myeloprolifrative neoplasm (including polycythemia vera) by different researchers.<sup>[[Polycythemia vera historical perspective|[1]]]</sup>


==Classification==
==Classification==
Line 14: Line 15:


==Pathophysiology==
==Pathophysiology==
Polycythemia is a number of symptoms that are caused by the increase of the total number of red blood cells in the body. This makes blood thicker in our blood vessels which may cause some problems. People with polycythemia will have an increase in their hemoglobin and hematocrit levels.
Polycythemia is a number of symptoms that are caused by the increase of the total number of [[red blood cell]]s in the body. This makes blood thicker in our blood vessels which may cause some problems. People with polycythemia will have an increase in their [[hemoglobin]] and [[hematocrit]] levels.


==Causes==
==Causes==
Polycythemia is caused by the increase of the total number of red blood cells in the body.
Polycythemia is caused by the increase of the total number of [[red blood cells]] in the body.


==Differentiating [Disease] from Other Diseases==
==Differentiating [Disease] from Other Diseases==
Polycythemia vera must be differentiated from [[chronic myelogenous leukemia]], [[essential thrombocythemia]], and [[primary myelofibrosis]].


==Epidemiology and Demographics==
==Epidemiology and Demographics==
The incidence of polycythemia is approximately 0.7 to 2.6 per 100,000 individuals in the US.


==Risk Factors==
==Risk Factors==

Revision as of 16:25, 19 October 2016

Polycythemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Polycythemia from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography or Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Interventions

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Polycythemia overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Polycythemia overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Polycythemia overview

CDC on Polycythemia overview

Polycythemia overview in the news

Blogs on Polycythemia overview

Directions to Hospitals Treating Polycythemia

Risk calculators and risk factors for Polycythemia overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Overview

Polycythemia is a condition in which there is a net increase in the total number of red blood cells in the body. The overproduction of red blood cells may be due to a primary process in the bone marrow (a so-called myeloproliferative syndrome), or it may be a reaction to chronically low oxygen levels or, rarely, a malignancy.

Historical Perspective

In 2005, a mutation in the JAK2 kinase (V617F) was found in multiple patients with myeloprolifrative neoplasm (including polycythemia vera) by different researchers.[1]

Classification

Based on the reasons, polycythemia is classified into two types; primary and secondary.

Pathophysiology

Polycythemia is a number of symptoms that are caused by the increase of the total number of red blood cells in the body. This makes blood thicker in our blood vessels which may cause some problems. People with polycythemia will have an increase in their hemoglobin and hematocrit levels.

Causes

Polycythemia is caused by the increase of the total number of red blood cells in the body.

Differentiating [Disease] from Other Diseases

Polycythemia vera must be differentiated from chronic myelogenous leukemiaessential thrombocythemia, and primary myelofibrosis.

Epidemiology and Demographics

The incidence of polycythemia is approximately 0.7 to 2.6 per 100,000 individuals in the US.

Risk Factors

Screening

Natural History, Complications, and Prognosis

Natural History

Complications

Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Prevention

References

Template:WS Template:WH